Olejniczak ET - Search Results

1

NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.

Huth JR, Olejniczak ET, Mendoza R, Liang H, Harris EA, Lupher ML Jr, Wilson AE, Fesik SW, Staunton DE. Huth JR, et al. Among authors: olejniczak et. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5231-6. doi: 10.1073/pnas.97.10.5231. Proc Natl Acad Sci U S A. 2000. PMID: 10805782 Free PMC article.

2

The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein.

Liang H, Olejniczak ET, Mao X, Nettesheim DG, Yu L, Thompson CB, Fesik SW. Liang H, et al. Among authors: olejniczak et. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11655-9. doi: 10.1073/pnas.91.24.11655. Proc Natl Acad Sci U S A. 1994. PMID: 7972119 Free PMC article.

3

NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain.

Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik SW. Huang B, et al. Among authors: olejniczak et. Nature. 1996 Dec 19-26;384(6610):638-41. doi: 10.1038/384638a0. Nature. 1996. PMID: 8967952

4

Changes in the NMR-derived motional parameters of the insulin receptor substrate 1 phosphotyrosine binding domain upon binding to an interleukin 4 receptor phosphopeptide.

Olejniczak ET, Zhou MM, Fesik SW. Olejniczak ET, et al. Biochemistry. 1997 Apr 8;36(14):4118-24. doi: 10.1021/bi963050i. Biochemistry. 1997. PMID: 9100005

5

Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1.

Betz SF, Schnuchel A, Wang H, Olejniczak ET, Meadows RP, Lipsky BP, Harris EA, Staunton DE, Fesik SW. Betz SF, et al. Among authors: olejniczak et. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7909-14. doi: 10.1073/pnas.95.14.7909. Proc Natl Acad Sci U S A. 1998. PMID: 9653114 Free PMC article.

6

NMR structure and mutagenesis of the N-terminal Dbl homology domain of the nucleotide exchange factor Trio.

Liu X, Wang H, Eberstadt M, Schnuchel A, Olejniczak ET, Meadows RP, Schkeryantz JM, Janowick DA, Harlan JE, Harris EA, Staunton DE, Fesik SW. Liu X, et al. Among authors: olejniczak et. Cell. 1998 Oct 16;95(2):269-77. doi: 10.1016/s0092-8674(00)81757-2. Cell. 1998. PMID: 9790533 Free article.

7

Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties.

Liu G, Huth JR, Olejniczak ET, Mendoza R, DeVries P, Leitza S, Reilly EB, Okasinski GF, Fesik SW, von Geldern TW. Liu G, et al. Among authors: olejniczak et. J Med Chem. 2001 Apr 12;44(8):1202-10. doi: 10.1021/jm000503f. J Med Chem. 2001. PMID: 11312920

8

Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus.

Huang Q, Petros AM, Virgin HW, Fesik SW, Olejniczak ET. Huang Q, et al. Among authors: olejniczak et. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3428-33. doi: 10.1073/pnas.062525799. Proc Natl Acad Sci U S A. 2002. PMID: 11904405 Free PMC article.

9

Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR.

Petros AM, Gunasekera A, Xu N, Olejniczak ET, Fesik SW. Petros AM, et al. Among authors: olejniczak et. FEBS Lett. 2004 Feb 13;559(1-3):171-4. doi: 10.1016/S0014-5793(04)00059-6. FEBS Lett. 2004. PMID: 14960327 Free article.

10

Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein.

Huang Q, Yu L, Petros AM, Gunasekera A, Liu Z, Xu N, Hajduk P, Mack J, Fesik SW, Olejniczak ET. Huang Q, et al. Among authors: olejniczak et. Biochemistry. 2004 May 25;43(20):6059-63. doi: 10.1021/bi036155b. Biochemistry. 2004. PMID: 15147189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page